trans-3-Hexyl-1-oxo-isochroman-4-carboxylic acid

ID: ALA446529

PubChem CID: 44582400

Max Phase: Preclinical

Molecular Formula: C16H20O4

Molecular Weight: 276.33

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCC[C@@H]1OC(=O)c2ccccc2[C@H]1C(=O)O

Standard InChI:  InChI=1S/C16H20O4/c1-2-3-4-5-10-13-14(15(17)18)11-8-6-7-9-12(11)16(19)20-13/h6-9,13-14H,2-5,10H2,1H3,(H,17,18)/t13-,14+/m0/s1

Standard InChI Key:  IECOAJSMYAHBPA-UONOGXRCSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
    4.0611  -22.4583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0599  -23.2857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7747  -23.6985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7729  -22.0455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4874  -22.4541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4931  -23.2811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2082  -23.6874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9222  -23.2712    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9164  -22.4442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1968  -22.0334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2128  -24.5123    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1899  -21.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8999  -20.7894    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4711  -20.8013    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6284  -22.0275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3453  -22.4358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0574  -22.0190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7743  -22.4273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4863  -22.0106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2032  -22.4189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  8  9  1  0
  9 10  1  0
  5  6  1  0
  7 11  2  0
 10 12  1  1
  2  3  1  0
  3  6  2  0
 12 13  1  0
 12 14  2  0
  1  2  2  0
  9 15  1  6
  5  4  2  0
 15 16  1  0
  4  1  1  0
 16 17  1  0
  5 10  1  0
 17 18  1  0
  6  7  1  0
 18 19  1  0
  7  8  1  0
 19 20  1  0
M  END

Associated Targets(non-human)

Fasn Fatty acid synthase (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 276.33Molecular Weight (Monoisotopic): 276.1362AlogP: 3.36#Rotatable Bonds: 6
Polar Surface Area: 63.60Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.07CX Basic pKa: CX LogP: 3.91CX LogD: 0.79
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.64Np Likeness Score: 0.82

References

1. Wang X, Lin J, Chen Y, Zhong W, Zhao G, Liu H, Li S, Wang L, Li S..  (2009)  Novel fatty acid synthase (FAS) inhibitors: design, synthesis, biological evaluation, and molecular docking studies.,  17  (5): [PMID:19223187] [10.1016/j.bmc.2009.01.050]

Source